Vioxx and the Merck Team Effort H. Presley, “Vioxx and the Merck Team Effort”. Kenan Institute for Ethics, Duke University , p. 22 p., 2009. Read more about Vioxx and the Merck Team EffortGoogle ScholarBibTeXTaggedMARCEndNote XMLRIS
IDEESE: Cases - Reporting Incidence of Severe Acute Respiratory Syndrome (SARS) M. J. Peterson and White, P. A., “IDEESE: Cases - Reporting Incidence of Severe Acute Respiratory Syndrome (SARS)”. Science, Technology and Society Initiative at the University of Massachusetts Amherst , 2010. Read more about IDEESE: Cases - Reporting Incidence of Severe Acute Respiratory Syndrome (SARS)Log in or register to post commentsGoogle ScholarBibTeXTaggedMARCEndNote XMLRIS
Prescription Drug Advertising (Case 15) “Prescription Drug Advertising (Case 15)”. Association for Practical and Professional Ethics, 2008. Read more about Prescription Drug Advertising (Case 15)Log in or register to post commentsGoogle ScholarBibTeXTaggedMARCEndNote XMLRIS
Drug Companies Funding FDA Research “Drug Companies Funding FDA Research”. Association for Practical and Professional Ethics, 2007. Read more about Drug Companies Funding FDA ResearchLog in or register to post commentsGoogle ScholarBibTeXTaggedMARCEndNote XMLRIS
Puredrug R. Ladenson, “Puredrug”. Association for Practical and Professional Ethics , 1996. Read more about PuredrugLog in or register to post commentsGoogle ScholarBibTeXTaggedMARCEndNote XMLRIS
Corporate Corruption of Medical Literature: Asbestos Studies Concealed by W.R. Grace & Co D. Egilman, Wallace, W., and Hom, C., “Corporate Corruption of Medical Literature: Asbestos Studies Concealed by W.R. Grace & Co”, Accountability in Research: Policies & Quality Assurance, vol. 6, no. 1/2, p. 127, 1998. Read more about Corporate Corruption of Medical Literature: Asbestos Studies Concealed by W.R. Grace & CoGoogle ScholarDOIBibTeXTaggedMARCEndNote XMLRIS